

Op-Art: The Shame of Crowdfunding Health CareAugust 26, 2019 |
Cartoonist Dustin Harbin fell off a bike into an outpouring of charity. But Americans shouldn’t have to seek out strangers to pay health bills
Quick Read
Op-Art: The Shame of Crowdfunding Health CareAugust 26, 2019 |
Cartoonist Dustin Harbin fell off a bike into an outpouring of charity. But Americans shouldn’t have to seek out strangers to pay health bills
Quick Read
The $6 Million Drug ClaimAugust 26, 2019 |
New treatments for rare diseases are changing the lives of patients, but the price can reach millions of dollars for a single person
Quick ReadAlan MacLeod writes, “The media invites us to be inspired by wholly unnecessary crises like UFC hopeful Jordan Williams, who uses dog insulin because he doesn’t have insurance”
Quick ReadForced off their parents’ insurance and faced with high insulin prices, young adults dangerously ration, stockpile, and turn to the black market for the medication they need to stay alive
Quick Read
The Promise and Perils of Cellular TherapiesJuly 16, 2019 |
New “living drugs”—made from a patient’s own cells—can cure once incurable cancers. But can we afford them?
Quick Read
For Some Critical Drugs, Low Prices Lead to ScarcityJune 19, 2019 |
Shortages of “supportive care” drugs, for chemotherapy-induced nausea or to protect the kidneys, can delay cancer treatments, said Yoram Unguru, a pediatric oncologist & bioethicist at Sinai and the Johns Hopkins Berman Institute of Bioethics. When he gets the hospital’s list of shortages, “I scream, I shout, I shake my head”
Quick ReadFederal prosecutors accused the company of illegally marketing its powerful fentanyl painkiller and of defrauding government health care programs
Quick ReadCancer drugs that speed onto the market based on encouraging preliminary studies often don’t show clear benefits when more careful follow-up trials are done, according to research published Tuesday
Quick Read